Insider Trading Alert - AA, BLUE And VLGEA Traded By Insiders

Yesterday, July 21, 2016, 27 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,395.00 to $7,781,550.00.

Highlighted Stocks Traded by Insiders:

Alcoa (AA) - FREE Research Report

Schmidt Ulrich, who is Director at Alcoa, bought 5,000 shares at $10.40 on July 21, 2016. Following this transaction, the Director owned 10,000 shares meaning that the stake was boosted by 100% with the 5,000-share transaction.

The shares most recently traded at $10.55, up $0.15, or 1.42% since the insider transaction. Historical insider transactions for Alcoa go as follows:

  • 4-Week # shares bought: 4,035
  • 4-Week # shares sold: 12,810
  • 12-Week # shares bought: 4,035
  • 12-Week # shares sold: 12,810
  • 24-Week # shares bought: 13,285
  • 24-Week # shares sold: 12,810

The average volume for Alcoa has been 22.4 million shares per day over the past 30 days. Alcoa has a market cap of $14.0 billion and is part of the basic materials sector and metals & mining industry. Shares are up 7.4% year-to-date as of the close of trading on Thursday.

Alcoa Inc. engages in engineering and manufacturing lightweight metals worldwide. The company operates through five segments: Alumina, Primary Metals, Global Rolled Products, Engineered Products and Solutions, and Transport and Construction Solutions. The stock currently has a dividend yield of 1.13%. Currently, there are 7 analysts who rate Alcoa a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AA - FREE

TheStreet Quant Ratings rates Alcoa as a hold. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including poor profit margins, weak operating cash flow and disappointing return on equity. Get the full Alcoa Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

bluebird bio (BLUE) - FREE Research Report

Sullivan Eric, who is Principal Accounting Officer at bluebird bio, sold 2,807 shares at $45.04 on July 21, 2016. Following this transaction, the Principal Accounting Officer owned 2,706 shares meaning that the stake was reduced by 50.92% with the 2,807-share transaction.

The shares most recently traded at $48.62, up $3.58, or 7.37% since the insider transaction. Historical insider transactions for bluebird bio go as follows:

  • 4-Week # shares bought: 3,528
  • 4-Week # shares sold: 2,931
  • 12-Week # shares bought: 3,528
  • 12-Week # shares sold: 2,931
  • 24-Week # shares bought: 3,528
  • 24-Week # shares sold: 2,931

The average volume for bluebird bio has been 894,600 shares per day over the past 30 days. Bluebird bio has a market cap of $1.8 billion and is part of the health care sector and drugs industry. Shares are down 23.89% year-to-date as of the close of trading on Thursday.

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Currently, there are 9 analysts who rate bluebird bio a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BLUE - FREE

TheStreet Quant Ratings rates bluebird bio as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full bluebird bio Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Village Super Market (VLGEA) - FREE Research Report

Estate of Perry Sumas, who is Shareholder at Village Super Market, sold 6,068 shares at $30.30 on July 21, 2016. Following this transaction, the Shareholder owned 414,907 shares meaning that the stake was reduced by 1.44% with the 6,068-share transaction.

The shares most recently traded at $29.76, down $0.54, or 1.8% since the insider transaction. Historical insider transactions for Village Super Market go as follows:

  • 4-Week # shares sold: 30,043
  • 12-Week # shares sold: 73,128
  • 24-Week # shares sold: 154,186

The average volume for Village Super Market has been 31,300 shares per day over the past 30 days. Village Super Market has a market cap of $423.0 million and is part of the services sector and retail industry. Shares are up 13.06% year-to-date as of the close of trading on Thursday.

Village Super Market, Inc. operates a chain of supermarkets in the United States. Its stores feature specialty departments, such as onsite bakery, an expanded delicatessen, natural and organic foods, ethnic and international foods, prepared foods, and pharmacies. The stock currently has a dividend yield of 3.34%. The company has a P/E ratio of 18.1. Currently, there are no analysts who rate Village Super Market a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLGEA - FREE

TheStreet Quant Ratings rates Village Super Market as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Village Super Market Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.